Reported about 1 year ago
The Taiwan Stock Exchange aims to expand the value of the capital market by nurturing local unicorns through the 'Dual Board' engine, with a focus on the biomedical sector among other innovative industries. With 17 companies listed on the Innovation Board, including 4 from the biomedical field, efforts are being made to encourage more flagship companies to join the market. Various initiatives such as creating a friendly fundraising and investment environment, policy improvements, and international connections are being implemented to support the growth of Taiwan's biomedical industry, which has shown significant market value increase and potential. Collaborations between industry and government entities aim to strengthen industry development and cultivate future unicorn companies through capital market support.
Source: YAHOO